imipramine and 2-(n-myristoylamino)-1-phenyl-1-propanol

imipramine has been researched along with 2-(n-myristoylamino)-1-phenyl-1-propanol in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aloy, MT; Alphonse, G; Ardail, D; Gérard, JP; Louisot, P; Rodriguez-Lafrasse, C; Rousson, R	1

Other Studies

1 other study(ies) available for imipramine and 2-(n-myristoylamino)-1-phenyl-1-propanol

Article	Year
Increasing endogenous ceramide using inhibitors of sphingolipid metabolism maximizes ionizing radiation-induced mitochondrial injury and apoptotic cell killing. International journal of cancer, 2002, Oct-20, Volume: 101, Issue:6 Topics: Apoptosis; Caspases; Cell Cycle; Ceramides; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Flow Cytometry; Glutathione; Humans; Imipramine; Jurkat Cells; Mitochondria; Morpholines; Myristates; Propanolamines; Radiation, Ionizing; Reactive Oxygen Species; Sphingolipids; Time Factors	2002

Article

Year

Increasing endogenous ceramide using inhibitors of sphingolipid metabolism maximizes ionizing radiation-induced mitochondrial injury and apoptotic cell killing.

International journal of cancer, 2002, Oct-20, Volume: 101, Issue:6

Topics: Apoptosis; Caspases; Cell Cycle; Ceramides; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Flow Cytometry; Glutathione; Humans; Imipramine; Jurkat Cells; Mitochondria; Morpholines; Myristates; Propanolamines; Radiation, Ionizing; Reactive Oxygen Species; Sphingolipids; Time Factors

2002